# Eledon Pharmaceuticals, Inc. (ELDN) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Eledon Pharmaceuticals, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/ELDN/mda/fy2025/): filed 2026-03-19; accession 0001193125-26-116164 (https://www.sec.gov/Archives/edgar/data/1404281/000119312526116164/eldn-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/ELDN/mda/fy2024/): filed 2025-03-20; accession 0000950170-25-042754 (https://www.sec.gov/Archives/edgar/data/1404281/000095017025042754/eldn-20241231.htm)
- [FY 2023 MD&A](/company/ELDN/mda/fy2023/): filed 2024-03-28; accession 0000950170-24-038091 (https://www.sec.gov/Archives/edgar/data/1404281/000095017024038091/eldn-20231231.htm)
- [FY 2022 MD&A](/company/ELDN/mda/fy2022/): filed 2023-03-30; accession 0000950170-23-011011 (https://www.sec.gov/Archives/edgar/data/1404281/000095017023011011/eldn-20221231.htm)
- [FY 2021 MD&A](/company/ELDN/mda/fy2021/): filed 2022-03-24; accession 0001564590-22-011698 (https://www.sec.gov/Archives/edgar/data/1404281/000156459022011698/eldn-10k_20211231.htm)

Back to /company/ELDN/